Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annu...(los_angeles_lasik_surgeons.htm onclick ...)

Date:11/5/2009

los_angeles_lasik_surgeons.htm" onclick="linkClick( this.href );" target="_blank" title="Los Angeles LASIK surgery and cataract expert surgeon">Los Angeles LASIK surgery and cataract expert surgeon, Dr. Jonathan Davidorf, was a featured speaker and instructor at the recent AAO meeting in San Francisco. Dr. Davidorf, who practices at Davidorf Eye Group, located in the Greater Los Angeles is a frequent participant in clinical studies aimed at advancements in ophthalmology, including LASIK, lens implants, and cataract surgery. Dr. Davidorf's presentation at the AAO meeting was entitled "Presbyopic IOL Calculations: The Aspheric ReSTOR D3 and Crystalens HD". This study examined the predictability of intraocular lens implant calculations in patients undergoing cataract surgery and implantation of these the ReSTOR D3 and Crystalens HD lenses. Dr. Davidorf concluded that the data demonstrated good predictability of IOL calculations in both lenses. Dr. Davidorf was also a featured instructor for "Astigmatism in the Cataract Patient". This skills transfer course was designed to teach cataract surgeons techniques to correct astigmatism in patients undergoing cataract eye surgery -essentially helping them to see without glasses.

Refractive surgeons Dr. Peter A. Rapoza and Dr. Michael B. Raizman Ophthalmic Consultants of Boston or OCB, were co-authors on a presentation demonstrating that wavefront-guided and conventional PRK followed by the applicaton of Mitomycin C are both effective procedures to treat residual hyperopia or myopia with and without astigmatism following prior LASIK with a mechanical keratome or the IntraLASE. These

Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9
Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
3. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
4. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
7. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations Symposium
10. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
11. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies